CI
The Cigna Group
NYSE · Health Care
$292.05
+7.52 (+2.64%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 233.08B | 207.38B | 21.34B | 20.79B | 19.67B |
| Net Income | 3.24B | 2.59B | 3.74B | 3.82B | 3.23B |
| EPS | — | — | — | — | — |
| Profit Margin | 1.4% | 1.3% | 17.5% | 18.4% | 16.4% |
| Rev Growth | +12.4% | +12.4% | +3.4% | +10.3% | -7.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 17.08B | 17.08B | 9.32B | 9.64B | 10.69B |
| Total Equity | 21.92B | 21.92B | 42.23B | 39.82B | 40.31B |
| D/E Ratio | 0.78 | 0.78 | 0.22 | 0.24 | 0.27 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 10.34B | 8.74B | 5.23B | 5.23B | 4.95B |
| Free Cash Flow | — | — | 2.80B | 3.42B | 2.15B |